Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 523

1.

Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.

Calvano CD, Aresta A, Iacovone M, De Benedetto GE, Zambonin CG, Battaglia M, Ditonno P, Rutigliano M, Bettocchi C.

J Pharm Biomed Anal. 2010 Mar 11;51(4):907-14. doi: 10.1016/j.jpba.2009.10.014. Epub 2009 Oct 30.

PMID:
19939598
2.

Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.

Callesen AK, Christensen Rd, Madsen JS, Vach W, Zapico E, Cold S, Jørgensen PE, Mogensen O, Kruse TA, Jensen ON.

Rapid Commun Mass Spectrom. 2008;22(3):291-300. doi: 10.1002/rcm.3364.

PMID:
18181248
3.

Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.

West-Nørager M, Kelstrup CD, Schou C, Høgdall EV, Høgdall CK, Heegaard NH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):30-7. Epub 2006 Nov 16.

PMID:
17112795
5.

Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, Ceglarek U.

Clin Chem. 2007 Mar;53(3):421-8. Epub 2007 Feb 1.

6.

SELDI-TOF-MS of saliva: methodology and pre-treatment effects.

Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):45-53. Epub 2006 Oct 27.

PMID:
17070117
7.

Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.

Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Mori K, Yamaya K, Ohyama C.

Oncol Rep. 2009 Jan;21(1):73-9.

PMID:
19082445
8.

Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.

Terracciano R, Pasqua L, Casadonte F, Frascà S, Preianò M, Falcone D, Savino R.

Bioconjug Chem. 2009 May 20;20(5):913-23. doi: 10.1021/bc800510f.

PMID:
19338374
9.

Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.

Feuerstein I, Rainer M, Bernardo K, Stecher G, Huck CW, Kofler K, Pelzer A, Horninger W, Klocker H, Bartsch G, Bonn GK.

J Proteome Res. 2005 Nov-Dec;4(6):2320-6.

PMID:
16335981
10.

Reproducibility in protein profiling by MALDI-TOF mass spectrometry.

Albrethsen J.

Clin Chem. 2007 May;53(5):852-8. Epub 2007 Mar 29. Review.

11.

Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.

Papale M, Pedicillo MC, Thatcher BJ, Di Paolo S, Lo Muzio L, Bufo P, Rocchetti MT, Centra M, Ranieri E, Gesualdo L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):205-13. Epub 2007 Jun 12.

PMID:
17613287
12.

Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.

Shevchenko VE, Arnotskaya NE, Zaridze DG.

Eur J Mass Spectrom (Chichester, Eng). 2010;16(4):539-49. doi: 10.1255/ejms.1080.

PMID:
20625202
13.

Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Amann JM, Chaurand P, Gonzalez A, Mobley JA, Massion PP, Carbone DP, Caprioli RM.

Clin Cancer Res. 2006 Sep 1;12(17):5142-50.

15.
16.

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.

Benkali K, Marquet P, Rérolle J, Le Meur Y, Gastinel L.

BMC Genomics. 2008 Nov 14;9:541. doi: 10.1186/1471-2164-9-541.

18.
19.
Items per page

Supplemental Content

Write to the Help Desk